Additionally, carriers of the rs2064863 G/T + G/G genotype demonstrated a lower risk (vs. T/T carriers) of developing large tumours and Child‐Pugh grade B or C.93Conversely, AURKA rs1047972 T/T (2.92‐fold) and T/C + T/T (3.38‐fold) genotypes were more prone to develop HCC compared to having the C/C genotype in an Egyptian cohort with Hepatitis C virus+ (HCV+) HCC.94 This evidence concerns the gene AURKA and hepatocellular carcinoma.